Zevert 12 SR Tablet contains Betahistine 12 mg as its active ingredient and is primarily indicated for the treatment of vertigo and balance disorders associated with Ménière’s disease. Betahistine acts as a histamine analogue, exerting vasodilatory effects on the inner ear’s blood vessels, thereby improving microcirculation and reducing endolymphatic pressure. This mechanism helps alleviate symptoms such as dizziness, tinnitus, and hearing loss commonly experienced in vestibular disorders. Zevert 12 SR is formulated as a sustained-release tablet to ensure a steady plasma concentration, enhancing therapeutic efficacy and minimizing side effects. It is generally well-tolerated, with adverse effects being rare but may include gastrointestinal disturbances, headache, or allergic reactions. The medication should be administered as prescribed by a healthcare professional, typically taken orally with or without food. Caution is advised in patients with peptic ulcer disease or asthma due to potential histamine-related effects. Zevert 12 SR is contraindicated in individuals with hypersensitivity to Betahistine or any tablet components. Regular monitoring and follow-up are recommended to assess treatment response and adjust dosage if necessary. This medication offers a targeted approach to managing vestibular symptoms, improving patient quality of life through effective symptom control.